tiprankstipranks
Trending News
More News >
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market

Viva Biotech Holdings (1873) Income Statement

Compare
1 Followers

Viva Biotech Holdings Income Statement

Last quarter (Q4 2024), Viva Biotech Holdings's total revenue was ¥1.00B, a decrease of -20.93% from the same quarter last year. In Q4, Viva Biotech Holdings's net income was ¥50.49M. See Viva Biotech Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B¥ 696.96M
Gross Profit
¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M¥ 304.87M
Operating Expenses
¥ 457.73M¥ 545.75M¥ 1.11B¥ 146.75M¥ 615.65M
Depreciation and Amortization
¥ 198.33M¥ 198.33M¥ 185.45M¥ 153.15M¥ 70.19M
EBITDA
¥ 428.00M¥ 391.01M¥ -89.04M¥ 369.94M¥ -223.89M
Operating Income
¥ 229.67M¥ 192.68M¥ 265.98M¥ 236.90M¥ 112.54M
Other Income/Expenses
¥ 66.04M¥ -248.64M¥ -728.51M¥ 110.80M¥ -471.78M
Pretax Income
¥ 295.70M¥ -55.95M¥ -459.17M¥ 347.70M¥ -356.21M
Net Income
¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M¥ -386.88M
Per Share Metrics
Basic EPS
¥ 0.08¥ -0.06¥ -0.28¥ 0.15¥ -0.25
Diluted EPS
¥ 0.06¥ -0.06¥ -0.28¥ 0.15¥ -0.25
Weighted Average Shares Outstanding
2.14B 1.94B 1.89B 1.91B 1.55B
Weighted Average Shares Outstanding (Diluted)
2.87B 2.03B 1.92B 1.97B 1.57B
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis